Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Tumor Biology
Published in: Tumor Biology 12/2016

01-12-2016 | Retraction Note

Retraction Note to: Downregulation of microRNA-217 and microRNA-646 acts as potential predictor biomarkers in progression, metastasis, and unfavorable prognosis of human osteosarcoma

Authors: Afshin Taheri Azam, Reza Bahador, Hamid Hesarikia, Mohammadreza Shakeri, Ali Yeganeh

Published in: Tumor Biology | Issue 12/2016

Login to get access

Excerpt

Retraction Note to: Tumor Biol (2016) 37:5769–5773 …
Metadata
Title
Retraction Note to: Downregulation of microRNA-217 and microRNA-646 acts as potential predictor biomarkers in progression, metastasis, and unfavorable prognosis of human osteosarcoma
Authors
Afshin Taheri Azam
Reza Bahador
Hamid Hesarikia
Mohammadreza Shakeri
Ali Yeganeh
Publication date
01-12-2016
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 12/2016
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-016-5478-z

Other articles of this Issue 12/2016

Tumor Biology 12/2016 Go to the issue

Review

Diverse roles of miR-335 in development and progression of cancers

Review

Involvement of microRNAs in HER2 signaling and trastuzumab treatment

Original Article

Interleukin 10 promotes immune response by increasing the survival of activated CD8+ T cells in human papillomavirus 16-infected cervical cancer

Original Article

Expression profile and prognostic value of SAV1 in patients with pancreatic ductal adenocarcinoma

Original Article

E-cadherin mediates adhesion of Aspergillus fumigatus to non-small cell lung cancer cells

Original Article

MYSM-1 suppresses migration and invasion in renal carcinoma through inhibiting epithelial-mesenchymal transition
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits